| EGFR mutation status on brain metastases from non-small cell lung cancer F Hsu, A De Caluwe, D Anderson, A Nichol, T Toriumi, C Ho Lung Cancer 96, 101-107, 2016 | 116 | 2016 |
| Immunotherapy in breast cancer: an overview of current strategies and perspectives V Debien, A De Caluwé, X Wang, M Piccart-Gebhart, VK Tuohy, ... NPJ Breast Cancer 9 (1), 7, 2023 | 96 | 2023 |
| PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer S Tuyaerts, AMT Van Nuffel, E Naert, PA Van Dam, P Vuylsteke, ... BMC cancer 19, 1-10, 2019 | 47 | 2019 |
| Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations F Hsu, A De Caluwe, D Anderson, A Nichol, T Toriumi, C Ho Current Oncology 24 (4), 228-233, 2017 | 44 | 2017 |
| Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study F Hsu, A Nichol, T Toriumi, A De Caluwe Acta Oncologica 56 (9), 1175-1180, 2017 | 40 | 2017 |
| Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma … EA De Jaeghere, S Tuyaerts, AMT Van Nuffel, A Belmans, K Bogaerts, ... Cancer Immunology, Immunotherapy 72 (2), 475-491, 2023 | 24 | 2023 |
| Radiation therapy for young women with early breast cancer: current state of the art I Meattini, M Lambertini, I Desideri, A De Caluwé, O Kaidar-Person, L Livi Critical reviews in oncology/hematology 137, 143-153, 2019 | 21 | 2019 |
| Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial A De Caluwé, L Buisseret, P Poortmans, D Van Gestel, R Salgado, ... BMC cancer 21, 1-9, 2021 | 17 | 2021 |
| Predictive biomarkers for response to immunotherapy in triple negative breast cancer: promises and challenges X Wang, L Collet, M Rediti, V Debien, A De Caluwé, D Venet, E Romano, ... Journal of clinical medicine 12 (3), 953, 2023 | 16 | 2023 |
| Split-VMAT technique to control the deep inspiration breath hold time for breast cancer radiotherapy S Poeta, Y Jourani, A De Caluwé, R Van den Begin, D Van Gestel, ... Radiation Oncology 16, 1-8, 2021 | 7 | 2021 |
| Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT I Ahrouch, D Van Gestel, O Koshariuk, C Kirkove, A Desmet, C Philippson, ... Radiotherapy and Oncology 164, 282-288, 2021 | 6 | 2021 |
| Post-neoadjuvant treatment strategies for patients with early breast cancer E Agostinetto, F Jacobs, V Debien, A De Caluwé, CF Pop, X Catteau, ... Cancers 14 (21), 5467, 2022 | 5 | 2022 |
| Dose-response in choroidal melanoma A De Caluwé, K Termote, D Van Gestel, E Van Limbergen Radiotherapy and Oncology 127 (3), 374-378, 2018 | 5 | 2018 |
| The incidence of symptomatic brain metastases from extra-pulmonary small cell carcinoma: Is there a role for prophylactic cranial irradiation in a clinically relevant … A De Caluwé, G Bowering, A Nichol, F Hsu Radiotherapy and Oncology 124 (1), 31-37, 2017 | 5 | 2017 |
| Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry C Philippson, S Larsen, S Simon, C Vandekerkhove, A De Caluwe, ... Breast Cancer Research 24 (1), 83, 2022 | 4 | 2022 |
| Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC … D Pasquier, L Bidaut, DE Oprea-Lager, MS Nandita, D Krug, L Collette, ... The Lancet Oncology 24 (8), e331-e343, 2023 | 3 | 2023 |
| Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT S Benkhaled, C Gomes da Silveira Cauduro, N Jullian, A Desmet, ... Frontiers in Oncology 12, 936088, 2022 | 3 | 2022 |
| Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers M Machiels, R Oulkadi, T Tramm, SR Stecklein, N Somaiah, A De Caluwé, ... The Breast, 2023 | 2 | 2023 |
| Delineation guidelines for the lymphatic target volumes in ‘prone crawl’radiotherapy treatment position for breast cancer patients MEJ Stouthandel, F Kayser, V Vakaet, R Khoury, P Deseyne, C Monten, ... Scientific reports 11 (1), 22529, 2021 | 2 | 2021 |
| Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary+ interstitial BT vs. SBRT. S Benkhaled, K Diakité, N Jullian, S Poeta, C Vandekerkhove, ... Radiation Oncology 18 (1), 105, 2023 | 1 | 2023 |
Hans PrenenProfessor oncology University Hospital AntwerpVerified email at uza.be
